X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2021/06/22/2250903/0/en/Histogen-and-Amerimmune-Announce-Positive-Top-Line-Study-Results-from-its-Phase-1-Study-of-Emricasan-in-Mild-Symptomatic-COVID-19-Patients.html
https://www.fiercebiotech.com/biotech/conatus-wields-ax-as-novartis-partnered-nash-drug-fails-again
https://endpts.com/suffering-novartis-partner-conatus-is-packing-it-in-on-nash-after-a-series-of-unfortunate-trial-events/
http://www.nasdaq.com/article/novartis-inks-deal-with-conatus-pharma-for-chronic-liver-diseases-20161219-01011
http://www.reuters.com/article/us-conatus-trial-idUSKBN0UJ25U20160105
Market Place
Share 
